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Human Papillomavirus (HPV) type 16 oncoprotein E7 plays a major role in cervical carcinogenesis by 
interacting with and functionally inactivating various host regulatory molecules. Long noncoding RNA 
(lncRNA) HOTAIR is one such regulator that recruits chromatin remodelling complex PRC2, creating 
gene silencing H3K27 me3 marks. Hence, we hypothesized that HOTAIR could be a potential target 
of E7, in HPV16 related cervical cancers (CaCx). We identified significant linear trend of progressive 
HOTAIR down-regulation through HPV negative controls, HPV16 positive non-malignants and CaCx 
samples. Majority of CaCx cases portrayed HOTAIR down-regulation in comparison to HPV negative 
controls, with corresponding up-regulation of HOTAIR target, HOXD10, and enrichment of cancer 
related pathways. However, a small subset had significantly higher HOTAIR expression, concomitant 
with high E7 expression and enrichment of metastatic pathways. Expression of HOTAIR and PRC2-
complex members (EZH2 and SUZ12), showed significant positive correlation with E7 expression 
in CaCx cases and E7 transfected C33A cell line, suggestive of interplay between E7 and HOTAIR. 
Functional inactivation of HOTAIR by direct interaction with E7 could also be predicted by in silico 
analysis and confirmed by RNA-Immunoprecipitation. Our study depicts one of the causal mechanisms 
of cervical carcinogenesis by HPV16 E7, through modulation of HOTAIR expression and function.
Cervical carcinoma (CaCx) is the second most prevalent cancer among women in India after breast 
cancer and the fourth most prevalent cancer among women worldwide1,2. Human Papillomavirus (HPV) 
is considered as the major etiologic contributor to the development of CaCx and is found in 99.7% of 
all the cases, of which, the high-risk types HPV16 and 18 are the most prevalent ones3,4. HPV16 alone 
contributes to more than 50% of the CaCx cases globally5.
HPV16 acts by frequently integrating into the host chromosome and replicates along with the host 
genome, which results in E2 gene disruption and consistent expression of the two HPV oncoproteins E6 
and E7 due to loss of E2 repressor activity6. The infected epithelial basal cells differentiate from the basal 
membrane to the superficial zone and the virus particles are shed with the sloughed-off epithelial cells. 
Moreover, E6 and E7 also facilitate persistence of episomal HPV genomes in undifferentiated cells of the 
cervical epithelium7. It is well established that oncoproteins E6 and E7 are the major transforming agents, 
leading to carcinogenesis. While E6 regulates the decay of the tumor suppressor p53, E7 leads to cellular 
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transformation by interacting with the PDZ domain of cellular proteins and pRb, thereby contributing 
to neoplastic progression8.
However, recent proteomics based studies9,10 have revealed other potential transforming targets of 
viral oncoproteins E6 and E7 and hence, novel mechanisms leading to cervical carcinogenesis. Such stud-
ies have identified that viral oncoproteins are known to interact with multitudes of host encoded mol-
ecules. This includes transcriptional regulators like Polycomb repressive complex containing E2F611,12. 
Interestingly, these HPV16 E7 interacting E2F6 transcription factors possess the ability of transcription-
ally regulating EZH2, a member of the Polycomb Repressive Complex 2 (PRC2)13,14. The PRC2 complex, 
on the other hand, has been reported to interact with a large number of long noncoding RNAs (lncR-
NAs). These lncRNAs have emerged as important regulators of transcription and disease progression, 
particularly of various cancers15,16. They are more than 200 nucleotides in length, do not code for any 
protein17, and possess a variety of functions, acting in both cis and trans fashion. This includes regulation 
of chromatin modifying complexes, functioning as antisense molecules to protein coding genes, organiz-
ing enhancer-activity. They also have strong implications in genomic reprogramming, such as induction 
of differentiation of somatic cells to pluripotent stem cells18–20. Several lncRNAs have been reported to 
be differentially expressed in a large variety of disease states, including cancer21–24.
One such regulatory lncRNA differentially expressed in a variety of cancers is HOX transcript anti-
sense intergenic RNA (HOTAIR). HOTAIR is a 2.2 kb lncRNA transcribed from the HOXC cluster located 
in chromosome 12q13.325. It is known to be deregulated in several cancers26–29 and can regulate global 
gene expression by associating with chromatin remodelling complexes30. HOTAIR bridges the Polycomb 
repressive complex 2 (PRC2) with the Lysine-specific histone demethylase 1 A complex (LSD1), leading 
to H3K27 me3 and demethylation of H3K4 me3 marks of their target genes, resulting in gene silencing 
globally. HOXD10 is one such HOTAIR target, which is silenced through this mechanism21,25,30.
Such global change at the transcriptional level is a common event associated with all cancers, includ-
ing CaCx cases expressing HPV16 oncoprotein E7. Furthermore, HPV16 positive CaCx cases also por-
tray a characteristic E7-dependent global reduction in the chromatin repressive H3K27 me3 mark14,31,32, 
indicative of probable impairment of HOTAIR function. Based on this rationale, we hypothesized that 
one of the mechanisms by which HPV16 E7 mediates its causal effect of activation of cancer-related 
pathway genes in CaCx pathogenesis, is through interplay with lncRNA HOTAIR. This ultimately affects 
the function of PRC2-complex recruitment by HOTAIR, which otherwise would normally act by creat-
ing chromatin repressive H3K27 me3 marks. Existing reports highlight the deregulation of the lncRNA 
HOTAIR in CaCx cases as well, reflecting its association with disease prognosis33,34, based on the met-
astatic potential of HOTAIR. However, we undertook the present study to test the hypotheses that (i) 
HOTAIR deregulation is involved in HPV16 related CaCx pathogenesis and (ii) E7 mediated cervical 
carcinogenesis is brought about through interplay between E7 and HOTAIR.
Our study revealed statistically significant down-regulation of HOTAIR expression in CaCx cases in 
comparison to the HPV negative controls. We also identified two categories of CaCx cases expressing 
low and high levels of HOTAIR, the latter depicting enrichment of processes related to cellular move-
ment and metastasis. Further studies helped us to predict and confirm the physical interaction between 
HOTAIR and E7 oncoprotein. This helped us to propose that HOTAIR could serve as one of the targets 
of the HPV16 oncoprotein E7 in the process of cervical carcinogenesis.
Results
HOTAIR is deregulated in HPV 16 positive cases as compared to the healthy HPV negative 
controls. To identify the role of HOTAIR in HPV16 positive CaCx cases, we determined HOTAIR 
expression in HPV negative controls (n = 37), HPV16 positive non-malignants (n = 28) and HPV16 
positive CaCx cases (n = 107). The analyzed samples were all histopathologically characterized and con-
firmed as HPV negative or HPV16 positive by PCR based methods described earlier35. The physical 
status of the HPV16 genome (episomal or integrated) were determined using APOT cum Taqman assay, 
as described earlier36. The CaCx case group comprised of two categories of samples. These were cases (i) 
harbouring episomal HPV16 (n = 63) and (ii) those with integrated HPV16 (n = 44).
Analysis revealed that HOTAIR was significantly down-regulated by 6.06-fold (p = 0.003) in HPV16 
positive CaCx cases, as compared to HPV negative controls (n = 37). HOTAIR deregulation was inde-
pendent of the physical status of the HPV16 genome, as CaCx cases harbouring both episomal and 
integrated HPV16 genomes showed comparable levels of HOTAIR down-regulation (episomal: 5.7-fold; 
p = 0.005 and integrated: 6.7-fold; p = 0.017). HPV16 positive non-malignants also showed HOTAIR 
down-regulation by 3.24-fold, which was not statistically significant (p = 0.442) (Fig.  1). However, a 
linear trend of progressive down-regulation of HOTAIR was recorded through HPV negative controls, 
HPV16 positive non-malignants and HPV16 positive CaCx cases (Supplementary Fig. S1).
ROC curve analysis to identify CaCx subgroups based on HOTAIR expression. Our observa-
tion of HOTAIR down-regulation among CaCx cases, compared to controls, was contrary to HOTAIR 
up-regulation in a variety of cancer types including hepatocellular carcinoma, breast, colon, oesopha-
geal and colorectal cancers21,26–29. Interestingly, however, most of these reports indicated the presence of 
subgroups among cancers harbouring low and high levels of HOTAIR expression, irrespective of overall 
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up-regulation of HOTAIR expression. Therefore, we undertook further analysis, to identify the existence 
of any subgroup showing high HOTAIR expression among our CaCx cases.
We used ROC curve analysis to confidently predict the cut-off level of HOTAIR expression, to classify 
the CaCx cases as expressing high HOTAIR or low HOTAIR. HPV16 positive CaCx cases could thus be 
subdivided into low and high HOTAIR (LH and HH) groups at a Δ Ct cut-off value of 7.79 (Fold change 
= 2.3 fold; Sensitivity = 0.879 and 1-Specificity = 0.595; p = 0.012), corresponding to an AUC of 0.638 
(Supplementary Methods, Supplementary Fig. S2).
Subsequent analysis revealed a statistically significant up-regulation of HOTAIR among 15.89% of the 
CaCx cases (39.4-fold, p < 0.001), as compared to the HPV negative controls. Such up-regulation was 
52.35-fold (p < 0.001) in HPV16 integrated cases and 28.2-fold (p = 0.007) in episomal cases. However, 
difference in HOTAIR expression between the episomal and integrated groups was not statistically sig-
nificant. About 84.11% of the CaCx cases on the other hand, showed a consistent down-regulation of 
HOTAIR expression (6.77-fold, p < 0.001), as compared to the HPV negative controls. The episomal 
samples portrayed a down-regulation by 6.19-fold (p < 0.001) and integrated samples showed 7.78-fold 
down-regulation (p < 0.001), which did not differ significantly. Thus, HOTAIR deregulation in HPV16 
positive CaCx cases was independent of the physical status of the viral genomes (Supplementary Fig. S3).
The LH and HH CaCx samples also harboured low and high levels of HPV16 E7 expression, respectively 
(Supplementary Fig. S3). The expression of E7 was significantly higher among CaCx cases (19.03-fold; 
p < 0.001) with HH as compared to the LH group, and this did not differ significantly between episomal 
(26.85-folds; p = 0.002) and integrated (10.6-folds; p = 0.004) CaCx cases. This observation identified 
that HOTAIR deregulation was probably correlated with HPV16 E7 expression, but independent of the 
viral integration status.
HOTAIR expression in HPV16 positive CaCx cases shows a correlation with HPV16 E7 expres-
sion. We employed two approaches, to confirm the correlation between E7 and HOTAIR expression, 
based on both clinical samples and CaCx cell lines. HOTAIR expression was positively and signifi-
cantly correlated with HPV16 E7 expression among the CaCx samples harbouring episomal or integrated 
HPV16 (Fig. 2a–c). Expression of HOTAIR and E7 correlated with viral load only among episomal CaCx 
cases (Supplementary Fig. S4). This was in concordance with an earlier report from our laboratory36 that 
identified similar correlation between E7 expression and viral load among CaCx cases with episomal 
HPV16, ensuring the expression of E7 from all episomal viral genomes. Taken together the observations 
point towards a possible dependence between HOTAIR and E7 expression.
In the second approach, we cloned HPV16 E7 into mammalian expression vector pcDNA3.1(+ ), and 
transfected this into the HPV negative CaCx cell line, C33 A. This resulted in a significant increase in 
HOTAIR expression concomitant with increase in HPV16 E7 expression (Fig. 2d–e). We also determined 
HOTAIR expression in HPV16 positive CaCx cell-lines, SiHa and Caski. HOTAIR expression was found 
to be higher among SiHa cells (Fig.  2f–g) that portray relatively higher E7 expression, as compared to 
Caski cells. Thus, both the clinical samples and cell line based observations confirmed that E7 could 
probably influence HOTAIR expression in CaCx cases.
HOXD10, a target of HOTAIR, shows a statistically significant up-regulation in expression 
among CaCx cases. HOTAIR deregulation is likely to influence the expression of its downstream 
Figure 1. HOTAIR deregulation in cervical cancers. Box plots representing distribution of HOTAIR 
expression levels among the different categories of cervical samples.
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target genes through altered recruitment of PRC2-complex. Hence, we determined the expression of 
HOXD10, a known target of HOTAIR. It is a transcription factor, which has been reported to be deregu-
lated in several cancer types21,37–40. We used a subset of samples selected for HOTAIR expression analysis 
comprising of CaCx cases (n = 70), HPV16 positive non-malignants (n = 11) and HPV negative controls 
(n = 19). HOXD10 expression was significantly higher among cases, irrespective of HPV16 physical sta-
tus (integrated or episomal) and HOTAIR expression levels (LH or HH), with a fold-change of 27.5 
(p = 0.012) as compared to HPV negative controls (Fig. 3a). The expression of HOXD10 also correlated 
negatively with HOTAIR expression among the CaCx cases (Fig.  3b), but not among the HPV nega-
tive controls. HOXD10 expression was significantly up-regulated among the LH CaCx cases (10.33-fold; 
p < 0.001) as compared to the HH CaCx cases (Fig. 3c). Such up-regulation was also recorded among 
the LH (48.5-fold; p = 0.0034) and HH (2.2-fold; p = 0.378) CaCx cases as compared to HPV negative 
controls, which was significant only among the LH cases. The findings potentially highlighted the inabil-
ity of HOTAIR to trans regulate its target HOXD10, in E7 expressing CaCx cases.
Gene expression profiling identifies distinct differences between LH and HH cases. The loss 
of HOXD10 silencing recorded above was suggestive of functional abrogation of HOTAIR in presence of 
E7, which could probably have an impact on global gene expression as well, among CaCx cases. Therefore, 
Figure 2. HOTAIR expression correlates positively with HPV16 E7 expression. (a–c) Correlation 
analysis between HOTAIR and HPV16 E7 expression among CaCx cases, episomal and integrated CaCx 
cases, respectively. (d,e) Box plots representing distribution of HPV16 E7 and HOTAIR expression levels 
respectively, in C33A cell line at various time points post-transfection (p. t.) of pcDNA3.1-HPV16 E7 vector. 
(f,g) Box plots representing distribution of expression levels of HPV16 E7 and HOTAIR among SiHa and 
Caski cell lines respectively.
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coupled with the identification of a subset of CaCx cases expressing high levels of HOTAIR compared 
to controls, it became essential to draw insights into the biological relevance of HOTAIR deregulation 
in CaCx cases. We therefore undertook global gene expression profiling using the Illumina HT-12_v4 
gene expression array employing 11 HPV negative controls, 11 HPV16 positive non-malignants and 
20 HPV16 positive cases comprising of 18 LH and 2 HH CaCx cases. The differentially expressed genes 
were subsequently identified and using the analysis pipeline illustrated in Fig. 4a, we identified the genes 
associated with disease development in the two categories of CaCx cases, as compared to the histopatho-
logically normal controls.
Analysis revealed that 327 genes were down-regulated and 866 genes were up-regulated among the 
LH CaCx cases, while 2134 and 2739 genes (Fig. 4b) were down and up-regulated respectively, among 
the HH CaCx cases as compared to the histopathologically normal controls (HPV negative as well as 
HPV16 positive). Hierarchical cluster analysis could demarcate the CaCx cases from the histopatholog-
ically normal controls (Fig. 4c).
Further, we attempted to obtain a global view of the altered and distinct biological functions that 
could be associated with CaCx pathogenesis, based on levels of HOTAIR expression among the CaCx 
cases. We performed functional analysis on the sets of differentially expressed genes characteristic of LH 
and HH CaCx cases, respectively, employing Ingenuity Pathway Analysis (IPA) software. The LH CaCx 
cases were characterized by a number of cellular intrinsic processes such as Cell Death and Survival, 
Gene Expression, Cell Cycle, Cellular Assembly and Organization, Cellular Function and Maintenance, 
Figure 3. Up-regulation of HOXD10 expression correlates negatively with HOTAIR. (a) Box plots 
representing distribution of HOXD10 expression levels among the different categories of cervical samples. 
(b) Correlation analysis between HOTAIR and HOXD10 expression among the CaCx cases. (c) Box plots 
representing distribution of relative expression levels of HOXD10 among the low and high HOTAIR 
category of CaCx cases.
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Tissue Development, DNA Replication, Recombination and Repair, etc. However, Cellular Growth and 
Proliferation (p = 1.28E-15) seemed to be the topmost biological process (Supplementary Table 1A–E) 
relevant for such cases, involving 236 genes, the maximum compared to the other biological processes 
involved. The HH CaCx cases were also characterized by cell intrinsic processes such as Cell Proliferation, 
Cell Cycle, Cellular Development, Cellular Growth, Cell Death and Survival, etc. However, such HH 
CaCx cases, were most prominently characterized by cell extrinsic processes such as Cellular Movement 
representing cell migration and invasion, and Cancer representing advanced malignant tumor, metasta-
sis, breast or ovarian cancer, pelvic cancer, head and neck cancer etc.(Supplementary Table S1 A–E). The 
top significantly altered pathways are listed in Supplementary Table S2 A–E.
PRC2-complex members, EZH2 and SUZ12, show E7-dependent increased expression in 
CaCx cases. HPV16 E7 harbours the ability to lower the global levels of H3K27 me3, which are 
known chromatin repressive marks, which facilitates global gene expression. Paradoxically, this has been 
recorded among E7 expressing cells, CaCx samples and cell lines, despite the high expression of EZH2, a 
PRC2-complex member12,14,31,32. HOTAIR-mediated PRC2-complex recruitment also creates H3K27 me3 
marks through EZH2 enzymatic activity21,25,30. Therefore, we estimated the expression of both EZH2 and 
SUZ12 by qRT-PCR, to confirm the impact of E7 on PRC2 complex members in our clinical samples 
and CaCx cell lines transfected with E7.
EZH2 and SUZ12 were both overexpressed among the CaCx cases by 23.4-fold (p = 0.034) and 
30.6-fold (p = 0.0056) respectively, compared to HPV negative controls (Fig. 5a–b). We also identified a 
positive correlation of EZH2 and SUZ12 mRNA expression, with HPV16 E7 mRNA expression among 
Figure 4. Microarray based global gene expression profiling. (a) Analysis pipeline utilised for 
identification of differentially expressed genes between sample groups. (b) Venn diagram depicting the 
number of genes differentially expressed among the low and high HOTAIR CaCx cases. (c) Hierarchical 
clustering distinctly separating the CaCx cases from the histopathologically normal controls (HPV negative 
and HPV16 positive) based on the differentially expressed genes.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:11724 | DOi: 10.1038/srep11724
the CaCx cases (Supplementary Fig. S5). In order to confirm the influence of E7 on the expression of 
PRC2 complex members, we employed E7 transfected C33 A cell line and evaluated the expression of 
EZH2 and SUZ12. E7 expression was found to be concomitant with increase in the expression of both 
the PRC2-complex members. While EZH2 was 4.54-folds up-regulated, SUZ12 showed an increase by 
6.37-fold at 72 hours post-transfection, as compared to the untransfected cells. The changes were found 
to be statistically significant (p < 0.001) for both (Fig.  5c–d). These changes were also recorded at the 
protein level, as confirmed by immunoblot analysis (Supplementary Fig. S5). Thus, we confirmed the 
potential role of E7 in modulating expression of the PRC2-complex members in CaCx cases. Our finding 
appeared to be in line with previous reports30–32.
HPV16 E7 possesses the ability to interact with HOTAIR. We further tested the hypothesis that 
the reported E7 mediated reduction in global H3K27 me3 marks31,32, in presence of high levels of PRC2 
complex members, could be the result of interference with HOTAIR function. To confirm this, we first 
used an in silico approach to identify the possibility of any physical interaction between E7 and HOTAIR, 
based on two RNA-protein interaction prediction tools: RPIseq (RNA-protein interaction prediction soft-
ware) and catRAPID (a software tool trained using known lncRNA-protein interactions, and used specif-
ically to predict lncRNA-protein interactions). Both the tools identified a strong propensity of interaction 
between HOTAIR and HPV16 E7. RPISeq predicted a strong interaction between the two, giving an RF 
Figure 5. Increased expression of PRC2-complex members, EZH2 and SUZ12, among CaCx cases 
appears to be HPV16 E7-dependent. (a,b) Box plots representing distribution of EZH2 and SUZ12 
expression levels respectively, among different categories of cervical samples. (c,d) Box plots representing 
distribution of EZH2 and SUZ12 expression levels in C33A cell line, at various time points post-transfection 
(p.t.) of pcDNA3.1-HPV16 E7 vector.
www.nature.com/scientificreports/
8Scientific RepoRts | 5:11724 | DOi: 10.1038/srep11724
classifier value of 0.8 and SVM classifier value of 0.77. To identify, which region of HOTAIR possessed 
the ability of interaction with HPV16 E7, we used catRAPID fragments algorithm. This tool identified 
both the 5′ and the 3′ ends of HOTAIR transcript to possess interaction propensities with HPV16 E7 
(Fig. 6a). catRAPID graphic also confirmed the results of catRAPID fragments and identified nucleotides 
1–770 (5′ -region) and 1700–2370 (3′ -region) of HOTAIR to show interaction propensities of 80 and 57 
respectively, and very high discriminative powers of 98% and 96% respectively (Fig. 6b–c). The predicted 
interactions highlighted regions of HOTAIR, which are known to interact with PRC2-LSD1 chromatin 
remodelling complex.
To confirm if HPV16 E7 interacted physically with HOTAIR, we used RNA-Immunoprecipitation 
(RIP), employing HPV16 E7 antibody followed by qRT-PCR. This showed enrichment of HOTAIR 
(7.17-fold), as compared to RIP with IgG antibody (negative control), in HPV16 E7 expressing C33 A 
cells. SUZ12 antibody based RIP also showed a significant enrichment of HOTAIR in untransfected C33 A 
cells (5.37-fold), as well as HPV16 E7 expressing C33 A cells (3.56-fold), which was lower in the latter 
(Fig. 6d, Supplementary Fig. S6). This observation provided strong evidence that HPV16 E7 physically 
interacted with HOTAIR. Hence, we predicted that such interaction probably excluded PRC2-complex 
from the HOTAIR binding-site, thereby affecting PRC2-complex recruitment and subsequent loss of 
gene silencing through reduction of H3K 27me3 levels.
Figure 6. HOTAIR interacts with HPV16 oncoprotein E7. (a) catRAPID fragments based prediction 
of interaction between HOTAIR and HPV16 E7 and maps HOTAIR interaction domains to nts 1–770 
(5′ -end) and nts 1700–2370 (3′ -end). (b,c) catRAPID graphic output confirming the interaction of HPV16 
E7 to the 5′ and 3′ ends of HOTAIR transcript as predicted by catRAPID fragments. (d) qRT-PCR results 
shows HOTAIR is significantly enriched with the SUZ12 antibody compared to IgG (control antibody) in 
untransfected C33A cells while a significant enrichment of HOTAIR was found both for HPV16 E7 and 
SUZ12 antibody in HPV16 E7 expressing C33A cells although lower for SUZ12.
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Discussion
In this study, our focus was to decipher the involvement of lncRNA HOTAIR, a regulator of gene expres-
sion through PRC2 recruitment, in CaCx pathogenesis. In view of the causal relevance of the viral onco-
protein E7 in CaCx pathogenesis, we further explored the interplay between E7 and HOTAIR in order 
to explore if HOTAIR could be targeted by E7 to achieve up-regulation of cancer related pathway genes. 
We determined the expression levels of HOTAIR and E7 in various categories of cervical tissue samples 
and cell lines. Employing in silico analysis and RNA-Immunoprecipitation assay, we interrogated the 
likelihood of physical interaction between the two.
Our study revealed a significant linear trend of progressive HOTAIR down-regulation through the 
discrete stages of CaCx development and its expression was E7-dependent. During early infection, E7 has 
been identified to create a milieu conducive for HPV16 DNA synthesis, by perturbing the keratinocyte 
differentiation program and inducing host DNA replication41. This could possibly be achieved through 
lowering of HOTAIR expression by low levels of E7, thereby prompting low levels of up-regulation of 
HOTAIR target genes, including, HOXD10. HOXD10 has been reported to be negatively correlated with 
rate of histologic differentiation in endometrial42 and breast cancers43. Hence, HOTAIR deregulation, 
under the impact of low levels of E7, could be reflective of gene expression deregulation as well, in early 
infection. This could perhaps facilitate an abortive life cycle leading to HPV16 persistence. Therefore, 
HOTAIR could probably serve as an early marker for singling out HPV16 positive women at risk of 
developing CaCx in the long run, for which further studies are warranted.
Although the observed down-regulation among the HPV16 positive CaCx cases was contradictory 
to the prevailing concept of HOTAIR up-regulation in most cancers21,26–29, including a couple of reports 
on cervical cancers33,34, almost all such reports reveal the existence of two subgroups. In most of these 
reports, 70–80% of the cancer samples harbour low HOTAIR expression, while 20–30% of the cancer 
samples show high HOTAIR expression. However, the reports on CaCx33,34 differed with respect to the 
proportion of samples with low and high HOTAIR expression. While one study portrayed equal propor-
tions33, the other34 identified proportions similar to that recorded by us where 84% and 16% of the CaCx 
samples portrayed LH or HH expression, respectively. But none of these studies considered the impact 
of HPV on HOTAIR deregulation. Our study design also differed from one of the studies33 distinctly, 
as we avoided the use of cancer adjacent normal tissues as controls. In such controls, there is a high 
probability of the presence of HPV infection at relatively high viral load, if not to the levels observed in 
cancer cells. Instead, we used normal samples that were HPV negative and included the HPV16 positive 
histopathologically normal tissues, as an intermediate group. This seemed to be biologically relevant in 
the context of viral load and E7 expression, which are established to be higher in CaCx cases, compared 
to HPV16 positive non-malignant samples44.
The correlation between E7 and HOTAIR expression among CaCx cases and cell lines was indicative 
of the role of E7 in regulating HOTAIR expression. However, the probable mechanism of this regula-
tion remains unclear and demands further study. A recent study, however, recorded down-regulation of 
HOTAIR expression in prostate cancer cells mediated by miR-34a45 and this miRNA has been reported to 
be differentially expressed in CaCx cases as well. The interplay between viral oncoproteins E6, E7 and the 
host encoded p53 is known to regulate miR-34a expression46. Thus, HOTAIR down-regulation among 
the CaCx cases could be brought about by E7-mediated gene regulatory mechanisms through miR-34a, 
which needs experimental validation.
HOTAIR down-regulation was concomitant with HOXD10 up-regulation among the CaCx cases, 
in our study. HOXD10 is a tumor suppressor and is known to be down-regulated in a variety of can-
cer types, exceptions being early stage HNSCC and oral squamous cell carcinoma, where HOXD10 is 
up-regulated39,40. We are the first to report HOXD10 up-regulation in HPV16 positive CaCx cases, in the 
context of HOTAIR down-regulation. This observation appears to be similar to that of Hakami et al., for 
HNSCCs39. The latter study showed that HOXD10 overexpression resulted in decreased cellular invasion 
and increased the proliferation and adhesion abilities of the cells, while knockdown of HOXD10 revealed 
opposite results. Such studies, including ours, reflected that increased HOXD10 in HPV16 positive CaCx 
cases provided a proliferative advantage to the cells.
Global gene expression profiling also identified an up-regulation of a large number of genes and 
revealed enrichment of a number of biological processes associated with cancer related mechanisms 
such as, Cell Growth and Proliferation, Cell Death and Survival, etc. among the LH and HH subtypes of 
CaCx cases. However, mechanistically the HH cases seemed to be distinct from the LH cases. The HH 
cases portrayed enrichment of processes like Cellular Movement involving migration and movement of 
cells, as well as, Cancer Related Processes associated with advanced malignant tumours and metasta-
sis. A distinct set of genes and pathways were also found to be differentially up-regulated among both 
categories of CaCx cases, LH and HH. These included Cell Cycle: G2/M DNA Damage Checkpoint 
Regulation, Cell Cycle Control of Chromosomal Replication, p53 Signaling, ATM Signaling, and Role of 
BRCA1 in DNA Damage Response etc. However, the HH CaCx cases appeared to be distinct from the 
LH cases in terms of genes and pathways associated with metastasis such as, Agranulocyte Adhesion and 
Diapedesis, Granulocyte Adhesion and Diapedesis, Glioma Invasiveness Signaling etc., which were not 
identified among LH cases. Thereby, we confirmed the metastatic potential of high levels of HOTAIR in 
HPV16 positive CaCx cases, a finding similar to reports on other cancers21,26–29. Based on such analysis, 
we further speculated that the HH and LH cases were likely to be prognostically distinct, warranting the 
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need for clinical correlation in subsequent studies. However, we failed to record any association between 
HOTAIR levels (LH or HH) and tumour stage or histopathological grades of the CaCx cases. This could 
probably be attributed to the homogeneous nature of our CaCx samples, which were all SCCs, majority 
being moderately differentiating and non-keratinizing types, with tumour stage III and above. Our find-
ings have therefore enriched the body of literature pertaining to the identification of molecular subtypes 
within various cancers, further justifying HOTAIR expression deregulation in HPV16 positive CaCx 
cases as a potential diagnostic marker.
Interestingly, we noted that irrespective of the status of HOTAIR expression, there was an up-regulation 
of a large number of genes in CaCx cases, which is expected if there is E7-mediated reduction of 
H3K27 me3 marks, as reported previously31,32. Such reduction in the levels of H3K 27me3 in HPV16 
positive cervical lesions and HPV16 E7 expressing cells has been attributed to induced KDM6A and 
KDM6B expression by Munger et al.12,31. But among the CaCx cases, this reduction occurs in presence 
of an E7-dependent increased expression of PRC2-complex members. This was suggestive of a probable 
functional impairment of HOTAIR in PRC2-complex recruitment and subsequent loss of gene silenc-
ing marks, causing up-regulation of a variety of cancer related pathways. Our speculation was further 
strengthened based on (i) in silico analysis revealing binding sites for E7 within the 5′ and 3′ domains of 
HOTAIR, which needs further validation and (ii) RIP/qRT-PCR confirmed physical interaction between 
HOTAIR and E7.
Thus, two distinct mechanisms could be responsible for the global gene expression up-regulation 
among the CaCx cases as indicated in Fig. 7. Among the LH cases, the reduced availability of HOTAIR 
transcripts for the recruitment of the PRC2-complex could be leading to reduced global H3K27 me3 
marks and subsequent up-regulation of the target genes. Among the HH cases, the abundant oncoprotein 
E7 could be competing with highly expressed PRC2-complex members for binding sites on the HOTAIR 
transcript. This could prevent the recruitment of PRC2-complex, thereby facilitating up-regulation of the 
target genes. Our study is the first of its kind to depict that one of the causal mechanisms of cervical 
Figure 7. Schematic illustration of E7-mediated regulation of global gene expression through HOTAIR 
by altering PRC2 activity .
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carcinogenesis mediated by HPV16 E7, was through modulation of HOTAIR expression and function. 
HOTAIR therefore appeared to be one of the many host molecules targeted by HPV16 E7, in cervical 
carcinogenesis.
In conclusion, we provided evidence of interplay between HPV16 E7 oncoprotein and lncRNA 
HOTAIR in regulating the PRC2-mediated global gene expression machinery, concomitant with the 
cellular processes involved in cell proliferation and metastasis. HPV16 E7, therefore seems to be a master 
regulatory molecule, facilitating CaCx development through this novel HOTAIR mediated regulation. 
This is a first glimpse towards understanding the molecular events critical to global transcriptional repro-
gramming, involving the interaction between a viral oncoprotein and lncRNA. Further studies employing 
chromatin Immunoprecipitation and deep sequencing (ChIP-Seq) for determining chromatin repressive 
marks (H3K27 me3) and activation marks (H3K4 me3) that are regulated by PRC2 and LSD-1 complexes 
respectively, are underway. Such data, together with our gene expression profiling data, could help in the 
delineation of gene sets that have altered gene silencing and activation marks at low and high HOTAIR 
levels. This could provide insights on disease pathogenesis by identification of markers related to disease 
aggressiveness and prognosis. Overall, the study holds potential of providing guidelines for the develop-
ment of prevention and therapeutic strategies for combating such cancers.
Methods
Sample Collection, DNA Isolation and HPV testing. The CaCx samples used for this study were 
derived from married subjects aged 28–80 years (median: 52 years) attending a cancer referral hospital 
(Saroj Gupta Cancer Centre and Research Institute, South 24 Parganas, West Bengal , India). All malig-
nant samples were histopathologically confirmed as invasive squamous cell carcinomas (majority were 
diagnosed as non-keratinizing and moderately differentiated squamous cell carcinoma pathologically) as 
per WHO classification and clinically diagnosed as stage III and above as per FIGO classification. The 
healthy control tissues were derived from married women aged 25–75 years (median: 48 years) from 
Calcutta Medical College and Hospital, Kolkata, West Bengal, India. There was no significant difference 
between the median age of the CaCx cases and the non-malignants. All control samples (collected from 
individuals without any prior history of cervical dysplasia/malignancy) were histopathologically con-
firmed as non-malignant and after testing for HPV were classified as HPV negative or positive. Of the 
HPV positive samples we selected only those with HPV16. Samples showing presence of HPV18 along 
with HPV16 were excluded from the study.
All samples, cases and non-malignant samples were collected from the subjects with informed con-
sent approved by the ethical committee of National Institute of Biomedical Genomics for human experi-
mentation. Details regarding DNA isolation, HPV screening and determination of HPV16, and physical 
status of HPV16 genomes have been described in details earlier from our laboratory35,47–49.
Plasmids and clones. Mammalian expression vector pcDNA3.1(+) was purchased from Invitrogen 
(Cat # V790-20) and used for cloning of HPV16 E7 ORF. HPV16 E7 region was amplified with 
primers (Forward Primer: GGAGGTACCGTCATGCATGGAGATACACCTACA, Reverse Primer: 
GAGGCGGCCGCTTTATGGTTTCTGAGAACAGAT) harbouring restriction sites for subsequent clon-
ing of the amplified fragment into pcDNA3.1(+ ). The amplified fragments and the vector DNA were 
digested using restriction enzymes NotI (NEB, Cat# R0189S) and KpnI (NEB, Cat# R0142S) and the 
digested products were ligated using T4 DNA Ligase (Roche, Cat# 10716359001) by incubating over-
night at 16 °C. The plasmid pcDNA3.1-HPV16 E7 was checked for insertion of the E7 fragment into the 
mammalian expression vector by Sanger sequencing.
Cell Culture and transfection. HPV negative cell line C33 A (Cervical carcinoma cell line derived 
from a 65-year old Caucasian female with cells being devoid of HPV DNA or RNA, http://www.atcc.
org/products/all/HTB-31.aspx) was obtained from the laboratory of Professor Sudhir Krishna (Cellular 
Organisation and Signalling, National Centre for Biological Sciences, Bangalore, India) and was cultured 
in DMEM (Gibco, Cat# 11995-065) supplemented with 10% FBS (Gibco, Cat# 16000-044), 50 Units/ml 
of penicillin and 50 μ g/ml of streptomycin (Gibco, Cat# 15070-063) at 37 °C and 5% CO2. C33 A cells 
were transfected using Lipofectamine 2000 reagent (Invitrogen, Cat# 11668-027) as per the manufactur-
er’s protocol, using 1 μ g of plasmid pcDNA3.1-HPV16 E7. The cells were harvested at three time points: 
24, 48 and 72 hrs post-transfection of cells with HPV16 E7. Empty vector pcDNA3.1(+ ) was used for 
mock. The cells were washed with 1X PBS, pH 7.4 (Gibco, Cat# 14190-144), trypsinized and collected 
by centrifugation at 300 g for 10 minutes. The transfected cells were used further for RNA and protein 
isolation. The transfection experiments were carried out in three sets, each in triplicates. The cells were 
monitored for mycoplasma contamination, employing standard protocols.
RNA Isolation and reverse transcription. RNA isolation methods and generation of cDNA 
using random hexamers and a combination of Oligo-dTP3 and random hexamers, are described in 
Supplementary Methods.
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Identification of the physical status of HPV16 and estimating the viral load. Confirmation 
of the integration or episomal status of HPV16 was carried out using APOT-coupled Taqman assay, as 
described previously36. Viral load was also estimated by Taqman assay, as described in earlier reports44.
Microarray based transcriptome profiling. RNA isolated from tissue samples was checked for 
integrity, using Agilent 2100 Bioanalyzer and Agilent RNA 6000 Nano reagents (Cat# 5067-1512). Only 
samples with RNA Integrity Number (RIN) of 6.0 and above were selected for the transcriptome analysis. 
Gene expression profiling was hence carried out on 20 CaCx case samples (18 low HOTAIR category and 
2 high HOTAIR category), 11 non-malignant HPV 16 positive samples and 11 HPV Negative Controls 
using the Illumina Human HT-12 v4 Expression Bead Chip Kit (Cat# BD-103-0204) and the scanning 
of the arrays was done, using the Illumina iScan Microarray scanner. The data has been submitted in the 
GEO database, NCBI (Accession No: GSE67522).
Gene expression profiles for all the categories of cervical samples were generated using one-color 
hybridization to whole human genome arrays, using Illumina’s 47,231 probes. The probe quality of the 
array was assessed before and after normalization and the background correction was done. Appropriate 
batch effects correction was done. To improve data quality, a filtering of the probes was applied. The 
probes containing repetitive sequences, binding to multiple sites of human transcriptome, were removed 
for further analysis. Downstream analysis was done to identify the differentially expressed genes, based 
on t-test among both the categories (low and high HOTAIR) of CaCx cases compared to histopatho-
logically normal controls (HPV negative controls and HPV16 positive non-malignant samples). We 
failed to record any differentially expressed genes, between HPV negative controls and HPV16 positive 
non-malignants. The p-values were determined and multiple testing corrections (Benjamini Hochberg 
method) done to remove the false discovery rate. The differentially expressed genes were selected on the 
basis of adjusted p < 0.05 and fold change of gene expression, compared to histopathologically normal 
controls (for up-regulation, fold change ≥ 1.5 and for down-regulation, fold change ≤ − 1.5).
To obtain a global view of the altered and distinct biological functions, functional analysis employing 
Ingenuity Pathway Analysis software (IPA) was done on the set of differentially expressed genes men-
tioned above. IPA is known to provide more robust results, rather than studying individual genes. The 
top biological processes were identified among the low and high HOTAIR expressing CaCx samples, to 
identify any mechanistic differences between the two categories.
Expression analysis using qRT-PCR. HOTAIR, E7, EZH2, SUZ12 and HOXD10 gene expressions 
were quantified in, CaCx samples with episomal (pure or concomitant) or integrated HPV16 (pure inte-
grated) HPV16, non-malignant HPV 16 positive samples and HPV negative controls. Expression analysis 
was done by qRT-PCR, on ABI 7900HT by relative quantification, using the comparative CT method. 
Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) was chosen as an internal control for normali-
zation. For all the samples, the median CT –values for the target genes and GAPDH was taken and the 
expression of target genes was normalized with that of GAPDH. 18S rRNA (Life Technologies TaqMan® 
Gene Expression Assay, Cat# 4352930E) served as the normalization control, for E7 expression estima-
tion. The dissociation curves and the amplification plots are provided in Supplementary Fig. S7. The 
primers used for the relative quantification are provided in Table 1.
Target Name Primer Sequence (5′- 3′) Product Length (bps)
HOTAIR F: GGT CCT GCT CCG CTT CGC AG 116
R: ACG CCC CTC CTT CCT CTC GC
HOXD10 F: GCA GGA GAA GGA AAG CAA AGA GGA A 159
R: CGC TCG CGG GTG AGG TAC AT
EZH2 F: CCC TGA CCT CTG TCT TAC TTG TGG A 119
R: CGT CAG ATG GTG CCA GCA ATA
SUZ12 F: AAA CGA AAT CGT GAG GAT GG 115
R: CCA TTT CCT GCA TGG CTA CT
GAPDH F:CAGCCTCAAGATCATCAGCA 106
R:TGTGGTCATGAGTCCTTCCA
HPV16 E7 F: AAG TGT GAC TCT ACG CTT CGG TT 78
R: GCC CAT TAA CAG GTC TTC CAA A  
Probe: (6-FAM) TGC GTA CAA AGC ACA CAC 
GTA GAC ATT CGT A (MGB)
Table 1.  Primer sequences for gene expression analysis using qRT-PCR.
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In silico prediction of lncRNA-protein interaction. In silico prediction was done to identify pos-
sible interaction between HOTAIR and HPV 16 E7 oncoprotein, using two RNA-protein interaction 
predictor tools, RPI-Seq (http://pridb.gdcb.iastate.edu/RPISeq/) and catRAPID (http://s.tartaglialab.com/
page/catrapid_group).
RNA-Immunoprecipitation (RIP) and qRT-PCR. C33 A (107 Untransfected and HPV 16 E7 
Transfected) cells were harvested by trypsinization and re-suspended in 2 ml PBS, 2 ml nuclear isola-
tion buffer (1.28 M sucrose; 40 mM Tris-HCl pH 7.5; 20 mM MgCl2; 4% Triton X-100), and 6 ml water 
on ice, for 20 min (with frequent mixing). Nuclei were pelleted by centrifugation at 2,500 g for 15 min. 
Nuclear pellet was re-suspended in 1 ml RIP buffer (150 mM KCl, 25 mM Tris pH 7.4, 5 mM EDTA, 
0.5 mM DTT, 0.5% NP-40, Protease Inhibitor Cocktail, 100 U/ml RNaseOUT Ribonuclease Inhibitor; 
Life Technologies). Re-suspended nuclei were split into two fractions of 500 μ l each (for Mock and IP) 
and were mechanically sheared using a Dounce homogenizer with 15–20 strokes. Nuclear membrane and 
debris were pelleted by centrifugation at 13,000 rpm, for 10 min. Antibody (5μg) to HPV16 E7 or SUZ12 
was added to supernatant for pull down along with mock controls and incubated for 2 hr at 4 °C, with 
gentle rotation. Then 40 μ l of Protein A Agarose (Pierce, Cat# 20333) beads were added and incubated for 
1 hr at 4 °C, with gentle rotation. Beads were pelleted at 2,500 rpm for 30 s, the supernatant was removed, 
and beads were re-suspended in 500 μ l RIP buffer. This was repeated for a total of three RIP washes, 
followed by one wash in PBS. Beads were re-suspended in 1 ml of Trizol. The immunoprecipitated pro-
teins were confirmed by western blot and the co-precipitated RNAs were isolated, followed by HOTAIR 
quantification by SYBR green qRT-PCR.
Statistical Analysis. Kolmogorov-Smirnov test was done to check for the normality of the qRT-PCR 
data. The changes in expression levels were tested for statistical significance using non-parametric test 
(Mann-Whitney U Test) for groups not showing normal distribution. For experimental sets showing nor-
mal distribution, t-test was used to compare the means of the different sets. Multiple sets of experiments 
using cell lines, were compared, using ANOVA for statistically significant differences in expression levels 
between the experimental categories. All statistical analyses was done using SPSS 16.0 and R package.
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